Socio-demographic and clinical determinants of dyslipidaemia in hypertensive patients at the Effia Nkwanta Hospital; a cross-sectional study Authors: Jonas Afful, Kirsten Nana Ama Anyomi, Emmanuel Duku, Ray Opoku Amaniampong, Daniel Damoah, Apenyine Okai Mary, Philemon Akwah, Joseph Cobbinah, Millicent Asare, Safuratu Zigani, Further Joy Hills, Gabriel Pezahso Kotam, Ibrahim Anyass Goumboundi, Tetteh Attoh, Asantewaa Agyen, Felix A Botchway, Justice Afrifa, Richard K D Ephraim Published: 2026 ABSTRACT AbstractDyslipidaemia and hypertension are significant independent risk factors for cardiovascular disease, and the two mostly exist together in clinical cases. This study aimed to determine the socio-demographic and clinical determinants of dyslipidaemia among hypertensive patients attending Effia Nkwanta Regional Hospital. A cross-sectional study was conducted among 347 adults with clinically diagnosed hypertension. Sociodemographic, lifestyle, anthropometric, and clinical data were collected using a structured questionnaire. Fasting serum lipid profiles were assessed using enzymatic methods. Dyslipidaemia was defined using standard lipid reference ranges. Data were analysed using SPSS version 26.0. Overall, 58.5% of participants had dyslipidaemia, with 52.7% being female. The residence of participants (p = 0.04), income (p = 0.008), history of smoking (p = 0.04), BMI (p = 0.02) and waist-hip ratio (p = 0.02) were significantly associated with dyslipidaemia status. The most common symptoms among all patients were early morning headaches and irregular heart rhythms. There was no significant difference in the prevalence of early morning headaches (p = 0.72) and irregular rhythms (p = 0.76) between participants with dyslipidemia and those without. Obese (OR = 0.432, p = 0.004) and overweight (OR = 0.401, p = 0.001) participants were less likely to have dyslipidaemia. Significant associations were also observed between occupation and triglyceride levels (p = 0.02) and LDL levels (p = 0.008). Dyslipidaemia is highly prevalent among hypertensive patients and is influenced by socio-demographic and clinical factors. Routine lipid screening and integrated cardiovascular risk management should be prioritized in the care of individuals with hypertension.Keywords: Hypertension, Obesity, Dyslipidaemia, Sociodemographic determinants, PrevalenceSubject terms: Cardiology, Diseases, Endocrinology, Health care, Medical research, Risk factors Introduction Dyslipidaemia is characterized by quantitative and/or qualitative abnormalities in plasma lipid levels. Quantitatively, it manifests as elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) as well as reduced levels of high-density lipoprotein cholesterol (HDL-C). Qualitatively, it involves changes in lipoprotein composition, such as increased triglyceride content and altered LDL particle properties1. Dyslipidaemia contributes to endothelial dysfunction and atherosclerosis, thereby increasing the risk of cardiovascular disease2,3. The World Health Organization (WHO) reports that 39% of adults have abnormal blood cholesterol levels, with a higher prevalence in women (World Health Organization)4. In Africa, the prevalence ranges from 5.2% to 89.9%5,6. In Ghana, studies have reported prevalence rates exceeding 60% in some rural populations7. Dyslipidaemia is common among individuals with cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity8. Hypertension affects over 1 billion people globally9 and accounts for 40% of cardiovascular-related deaths10. Major risk factors include smoking, poor dietary habits, and lack of physical activity11. The May Measurement Month 2018 campaign reported a global hypertension prevalence of 33.4%12. In Africa, a systematic review reported a hypertension prevalence of 57%13. In Ghana, the 2014 Demographic and Health Survey indicated that 13% of adults had hypertension, of whom fewer than one-quarter had adequate blood pressure control14. Dyslipidaemia and hypertension are independent risk factors of cardiovascular disease and often coexist in clinical practice15–18. Epidemiological studies have demonstrated positive associations between increasing blood pressure and elevated lipid levels19–21. These conditions share common pathophysiological mechanisms, including obesity, insulin resistance, chronic inflammation, and dysregulation of adipocytokine secretion from adipose tissue22. White adipose tissue (WAT) produces adipokines which regulate homeostasis, insulin sensitivity, appetite, and energy metabolism23. Impaired secretion can cause inflammation, causing dyslipidaemia and hypertension24. The co-existence is termed ‘LIPITENSION’25, with prevalence ranging from 15% to 31%26,27. Although dyslipidaemia and hypertension frequently coexist and contribute substantially to cardiovascular morbidity, data on their combined burden and determinants among hypertensive patients in Ghana remain limited. Most available studies in sub-Saharan Africa have focused on the general population, with little emphasis on high-risk clinical groups. Furthermore, socio-demographic and lifestyle factors influencing dyslipidaemia may vary across settings due to differences in urbanization, dietary patterns, and healthcare access. Therefore, this study aimed to determine the prevalence and socio-demographic and clinical determinants of dyslipidaemia among hypertensive patients attending Effia Nkwanta Regional Hospital in Ghana. Understanding these factors is essential for developing targeted prevention and management strategies in this high-risk population. Methodology Study design, population and sample size A cross-sectional design was used to assess the socio-demographic and clinical determinants of dyslipidaemia in hypertensive patients at the Effia Nkwanta Regional Hospital (ENRH) in Ghana. Participants were recruited irrespective of blood pressure control status. The ENRH is a major health facility providing secondary and tertiary healthcare services in the Sekondi-Takoradi metropolis and a referral center for the Western region. We determined the sample size using the Cochran’s sample size formula [N = Z² p (1-p)/d²]. Using a confidence level of 95% with its corresponding Z score of 1.96, a population prevalence (p) of 27%14, and a 5% margin of error (d), we found the estimated sample size to be 303. We conveniently recruited 347 participants for the study. The data collection spanned August 2023 to November 2023. Eligibility criteria Patients attending Effia Nkwanta Regional Hospital with a documented diagnosis of hypertension for at least six months and who were able to provide informed consent were enrolled in the study. Hypertension diagnosis was confirmed based on documented clinical records and defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, or current use of antihypertensive medication, in accordance with the International Society of Hypertension (ISH) guidelines28. Hypertensive patients on lipid-lowering drugs, pregnant women, patients with secondary hypertension and those below 18 years of age were excluded. After the exclusion of 3 participants based on the criteria above, we had 347 participants. We defined secondary hypertension as increased blood pressure caused by identifiable underlying factors29. Socio-demographic and clinical history Socio-demographic data (age, sex, education status, residence, marital status, occupation, income, and religion), dietary habits (fruit consumption and alcohol intake) Clinical history (smoking, physical activity, family history of hypertension) were obtained using pretested interviewer-administered questionnaires with close-ended questions and predefined responses. The questionnaire was adapted from the WHO STEPS instrument for surveillance of chronic disease risk30. Anthropometric measurements The body weight was measured using a weighing balance (Seca, Hamburg, Deutschland). The body height was measured with participants standing upright and barefooted using a stadiometer (LINDELS, Klippan, Sweden). The body mass index (BMI) was then calculated as a fraction of weight in kilograms to height in meters squared (kg/m²). The BMI was categorized as underweight (< 18.5 kg/m²), Normal (18.5–24.5 kg/m²), overweight (25–30 kg/m²) and Obese (> 30 kg/m²). The hip and waist circumference (to the nearest cm) were also measured using a measuring tape. The waist-hip ratio was calculated as waist circumference in cm divided by hip circumference in cm and categorized as normal (≤ 0.8) and high (> 0.8) for females, and normal (≤ 0.9) and high (> 0.9) for males according to the world health organization standards (WHO, 2008). The equipment for body weight and height measurement was calibrated before and during the data collection period. Cardiovascular risk estimation The WHO non-laboratory CVD risk prediction chart for the Western Sub-Saharan Africa region was used to estimate the 10-year cardiovascular risk among participants aged 40–74 years. Participants were categorized into low risk (< 10%), moderate risk (10–<20%), and high risk (≥ 20%) groups according to the WHO classification31. Blood pressure Systolic and diastolic blood pressure of the participants was measured using a sphygmomanometer after patients rested for 10 min32. Three measurements with 5 minutes’ intervals were taken and the mean values were recorded. Data were also stratified based on the control of hypertension. Uncontrolled hypertension was defined as an average systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg among hypertensive patients on treatment at the time of assessment. Controlled hypertension was defined as an average systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg among hypertensive patients on treatment26. Lipid levels Following an overnight fast, 5 ml of venous blood samples were collected from each participant into a serum separator tube. The samples were allowed to clot after which they were centrifuged to obtain serum. The serum was dispensed into Eppendorf tubes which were later used for assessment of serum lipids. TC, TG and HDL-c levels were measured. LDL-c was calculated using the Friedwald equation: LDL-c = TC – (HDL-c + TG/2.2) mmol/L. The methods adopted for determining the biochemical profiles were predetermined by the reagent manufacturer (Selectra Pro S, elitech Group, France) using an automated chemical analyzer (Selectra Pro S.) Non-HDL cholesterol and coronary risk (CR) were also calculated. CR was calculated as the ratio of TC to HDL-c (TC/HDL-c)33. In addition, lipid ratios including total cholesterol to high-density lipoprotein cholesterol ratio (TC/HDL-C), low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (LDL-C/HDL-C), and triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) were calculated as indicators of atherogenic cardiovascular risk. The lipid values were flagged as normal, high, or low using the reference ranges set by the ENRH local laboratory for triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL): TG < 150 mg/dL (normal), LDL < 100 mg/dL (optimal), and HDL > 40 mg/dL. Dyslipidaemia was defined according to the 2019 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines for the management of dyslipidaemia34. Elevated lipid levels were defined as total cholesterol ≥ 6.2 mmol/L (240 mg/dL), LDL-C ≥ 4.1 mmol/L (160 mg/dL), triglycerides ≥ 2.3 mmol/L (200 mg/dL), and low HDL-C < 1.0 mmol/L (40 mg/dL) for men and < 1.3 mmol/L (50 mg/dL) for women. In this study, high TC, and/or high LDL-C, and/or low HDL-C and/or high TG was regarded as dyslipidemia. Physical activity assessment and classification Physical activity was classified according to the World Health Organization (WHO) population-level criteria as low, moderate, and high physical activity. Participants were classified as having high physical activity if they engaged in vigorous-intensity activity on at least 3 days, or if they reported 7 or more days of any combination of walking, moderate- or vigorous-intensity activities. Moderate physical activity was defined as fulfilling any of the following: engagement in vigorous-intensity activity for at least 20 min per day on 3 or more days; moderate-intensity activity or walking for at least 30 min per day on 5 or more days; or any combination of walking, moderate- or vigorous-intensity activities on 5 or more days. Participants who did not meet any of the above criteria were classified as having low (sedentary) physical activity35. Data analysis Data entry and organization were initially conducted using Microsoft Excel 2016. The data were then extracted to the Statistical Package for Social Sciences (IBM SPSS Statistics version 26.0). Descriptive statistics, such as frequencies, percentages, and graphical representations, were used to summarize and present the data. The chi-square test was used to examine associations between socio-demographic factors and dyslipidaemia. Comparative statistical analysis was performed to evaluate the differences in measures of obesity, blood pressure, and lipid profiles between individuals with and without dyslipidaemia. Results were visualized using violin plots to illustrate the distribution and central tendencies of the variables. We determined the strength of association between socio-demographics and dyslipidaemia using univariate and multivariate regression models. Mean lipid ratios were compared across categorical variables using independent samples t-test or one-way ANOVA as appropriate. A p-value of ≤ 0.05 was considered statistically significant for all analyses. Results The ages of the participants ranged from 25 to 85 years. Most (58.5%) of the participants had dyslipidaemia (Fig. 1). Prevalence of dyslipidemia among study participants. The mean age of participants with dyslipidaemia was similar to those without dyslipidaemia (49.59 ± 11.89 vs. 49.37 ± 11.91; p = 0.866). Participants with dyslipidaemia were mostly females (52.7%), within 41–50 years (39.4%), Christians (78.8%), and married (68.0%). About 81% of participants with dyslipidaemia had sedentary occupation. History of smoking was found only in participants with dyslipidaemia (3%). Place of residence of participants (p = 0.04), income (p = 0.01), and history of smoking (p = 0.04) were significantly associated with dyslipidaemia status. Age (p = 0.87), sex (p = 0.31), religion (p = 0.96), educational level (p = 0.10), marital status (p = 0.74), occupation (p = 0.10), ethnicity (p = 0.11), and history of alcohol (p = 0.30) intake were all not associated with dyslipidaemia status (Table 1). Table 1Socio-demographic characteristics in relation to dyslipidemia status.VariableDyslipidemia n(%)No Dyslipidemia n(%)P-value(N = 203)(N = 144)Age (yrs)49.59 ± 11.8949.37 ± 11.910.866 Age group 0.11821–305 (2.5)7 (4.9)31–4037 (18.2)27 (18.8)41–5080 (39.4)54 (37.5)51–6051 (25.1)28 (19.4)61–7014 (6.9)21 (14.6)> 7016 (6.9)7 (4.9) Sex 0.314Male96 (47.3)76 (52.8)Female107 (52.7)68 (47.2) Religion 0.964None1 (0.5)1 (0.7)Christianity160 (78.8)114 (79.2)Islam42 (20.7)29 (20.1) Educational level 0.098No formal education19 (9.4)24 (16.7)Primary2 (1.0)3 (2.1)JHS14 (6.9)4 (2.8)SHS39 (19.2)22 (15.3)Tertiary129 (63.5)91 (63.2) Marital status 0.736Single30 (14.8)21 (14.6)Married138 (68.0)93 (64.6)Divorced11 (5.4)7 (4.9)Widowed24 (11.8)23 (16.0) Occupation 0.102Unemployed11 (5.4)5 (3.5)Sedentary165 (81.3)129 (89.6)Non-sedentary27 (13.3)10 (6.9) Ethnicity 0.113Akan71 (35.0)68 (47.2)Ewe29 (14.3)17 (11.8)Ga-Adangbe32 (15.8)13 (9.0)Guan32 (15.8)17 (11.8)Mole-Dagbani39 (19.2)29 (20.1) Residence 0.042 Urban124 (61.1)75 (52.1)Peri-urban52 (25.6)35 (24.3)Rural27 (13.3)34 (23.6) Income (cedis) 0.008 No answer6 (3.0)1 (0.7)< 100029 (14.3)40 (27.8)1000–3000107 (52.7)71 (49.3)> 300061 (30.0)32 (22.2)Smoking6 (3.0)0 (0.0) 0.037 Alcohol intake32 (15.8)17 (11.8)0.297 Socio-demographic characteristics in relation to dyslipidemia status. Table 2 presents the distribution of TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratios across selected socio-demographic and clinical characteristics among the study participants. Overall, participants with dyslipidaemia demonstrated significantly higher TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratios compared with participants without dyslipidaemia (p < 0.001). Male participants had significantly elevated TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratios compared with females (p = 0.028, p = 0.034, and p = 0.001, respectively). Table 2Atherogenic lipid ratios stratified by selected socio-demographic and clinical characteristics.VariableCategoryTC/HDL-C mean ± SDp-valueLDL-C/HDL-C mean ± SDp-valueTG/HDL-C mean ± SDp-valueSexMale4.11 ± 2.610.0282.63 ± 2.440.0341.07 ± 0.770.001Female3.62 ± 1.242.19 ± 1.110.85 ± 0.42SmokingNo3.86 ± 2.060.1542.40 ± 1.910.2080.95 ± 0.630.101Yes4.41 ± 0.792.87 ± 0.781.14 ± 0.22Physical activityNo3.90 ± 2.640.8132.43 ± 2.520.8560.88 ± 0.450.045Yes3.84 ± 1.452.39 ± 1.241.01 ± 0.73BMI statusNormal4.07 ± 1.480.0632.59 ± 1.320.0741.05 ± 0.620.120Overweight4.03 ± 2.892.56 ± 2.720.95 ± 0.70Obese3.50 ± 1.092.08 ± 0.930.88 ± 0.54Dyslipidaemia statusDyslipidaemia4.16 ± 2.19< 0.0012.65 ± 2.04< 0.0011.03 ± 0.67< 0.001No dyslipidaemia2.69 ± 0.451.41 ± 0.390.65 ± 0.24 Atherogenic lipid ratios stratified by selected socio-demographic and clinical characteristics. Participants who engaged in physical activity had a different TG/HDL-C ratio compared with those who did not engage in physical activity (p = 0.045), although no significant differences were observed for TC/HDL-C and LDL-C/HDL-C ratios. Smoking status and BMI category were not significantly associated with any of the lipid ratios (p > 0.05). Most of the participants had been clinically diagnosed with hypertension for a duration of 1 to 5 years and had been on blood pressure-lowering medications for the same period. The most common symptoms were early morning headaches and irregular heart rhythms. There was no significant difference in the prevalence of early morning headaches (p = 0.72) and irregular rhythms (p = 0.76) between participants with dyslipidaemia and those without. BMI grades (p = 0.02) and waist-hip ratio (p = 0.02) were significantly associated with dyslipidaemia status. Blood pressure control was not associated with dyslipidaemia status, with 98% and 98.6% of participants with and without dyslipidaemia having uncontrolled BP respectively. Most participants were classified as low risk, and the distribution of low, moderate, and high risk did not differ significantly between participants with and without dyslipidaemia (Table 3). Table 3Clinical characteristics in relation to dyslipidemia status.VariableDyslipidemiaNo DyslipidemiaP-value(N = 203)(N = 144)Early morning headache139 (68.5)96 (66.7)0.723Irregular heart rhythms108 (53.2)79 (54.9)0.760Shortness of breath84 (41.4)53 (36.8)0.390Vomiting29 (14.3)18 (12.5)0.632Hypertensive drugs intake198 (97.5)114 (100.0)0.058 Duration on drug 0.052< 1 years67 (33.0)33 (22.9)1–5 years72 (35.5)58 (40.3)6–10 years26 (12.8)19 (13.2)> 10 years33 (16.3)34 (23.6) Duration of hypertension 0.252< 1 years67 (33.0)32 (22.2)1–5 years71 (35.0)58 (40.3)6–10 years29 (14.3)21 (14.6)11–15 years18 (8.9)18 (12.5)> 15 years18 (8.9)15 (10.4)Family history of hypertension94 (46.3)78 (54.2)0.149 Physical activity 0.350Low (sedentary)43 (21.2)31 (21.6)Moderate59 (29.1)28 (19.4)High9 (4.4)27 (18.7) BMI grades 0.021 Normal71 (35.0)31 (21.5)Overweight72 (35.5)57 (39.6)Obese60 (29.6)56 (38.9) Waist-Hip ratio 0.016 Obese96 (47.3)87 (60.4)Non-obese107 (52.7)57 (39.6) BP control 0.682Controlled BP4 (2.0)2 (1.4)Uncontrolled BP199 (98.0)142 (98.6) *10-year CVD risk Low (< 10%)51 (91.1%)170 (80.6%)0.157Moderate (10–<20%)4 (7.1%)37 (17.5%)High (≥ 20%)1 (1.8%)4 (1.9%)BP: blood pressure.*For the WHO CVD risk score, among the 268 eligible participants aged 40–74 years. Clinical characteristics in relation to dyslipidemia status. BP: blood pressure. *For the WHO CVD risk score, among the 268 eligible participants aged 40–74 years. The measures of obesity and blood pressure of the participants stratified by dyslipidemia are presented in Fig. 2. Median BMI (P = 0.05) and waist-hip ratio (P = 0.005) were significantly higher among participants without dyslipidemia than those with dyslipidemia. However, median coronary risk (CR) and non-HDL cholesterol were significantly increased in those with dyslipidemia compared to those without dyslipidemia (P < 0.0001). Medians of weight, waist circumference, systolic and diastolic blood pressure were all comparable between those with and without dyslipidemia (P > 0.05). Measures of obesity and blood pressure stratified by dyslipidemia. The socio-demographic characteristics of participants stratified by measures of dyslipidaemia are summarized in Table 4. Participants with high total cholesterol, high triglycerides, low HDL, and high LDL were predominantly aged 41–50 years. High total cholesterol and high LDL were more common in males (52.2% and 56.0%, respectively), while low HDL was more common in females (58.6%). Urban residence was also predominant among participants with lipid abnormalities, ranging from 52.2% (high total cholesterol) to 69.1% (high triglycerides). We found significant associations between occupation and triglyceride levels (p = 0.02), as well as occupation and LDL levels (p = 0.008). Sex (p = 0.02), educational attainment (p = 0.04), ethnicity (p = 0.03), residence (p = 0.02), and income (p = 0.04) were significantly associated with HDL levels. Table 4Socio-demographic characteristics stratified by measures of dyslipidemia.VariablesHigh TCHigh TGLow HDLHigh LDL(N = 69)(N = 55)(N = 128)(N = 75) Age group (yrs) 21–302 (2.9)2 (3.6)1 (0.8)3 (4.0)31–4013 (18.8)10 (18.2)21 (16.4)9 (12.0)41–5023 (33.3)25 (45.5)54 (42.2)23 (30.7)51–6022 (31.9)9 (16.4)30 (23.4)27 (36.0)61–705 (7.2)3 (5.5)10 (7.8)7 (9.3)> 704 (5.8)6 (10.9)12 (9.4)6 (8.0) Sex Male36 (52.2)32 (58.2)53 (41.4) *42 (56.0)Female33 (47.8)23 (41.8)75 (58.6)33 (44.0) Educational level No formaleducation7 (10.1)8 (14.5)9 (7.0) *10 (13.3)Primary2 (2.9)0 (0.0)1 (0.8)2 (2.7)JHS5 (7.2)1 (1.8)11 (8.6)6 (8.0)SHS13 (18.8)7 (12.7)25 (19.5)18 (24.0)Tertiary42 (60.9)39 (70.9)82 (64.1)39 (52.0) Marital status Single7 (10.1)8 (14.5)17 (13.3)6 (8.0)Married52 (75.4)38 (69.1)87 (68.0)57 (76.0)Divorced3 (4.3)1 (1.8)9 (7.0)3 (4.0)Widowed7 (10.1)8 (14.5)15 (11.7)9 (12.0) Occupation Unemployed3 (4.3)6 (10.9) *5 (3.9)6 (8.0) *Sedentary54 (78.3)45 (81.8)105 (82.0)55 (73.3)Non-sedentary12 (17.4)4 (7.3)18 (14.1)14 (18.7) Ethnicity Akan26 (37.7)30 (54.5)40 (31.3) *26 (34.7)Ewe10 (14.5)6 (10.9)21 (16.4)8 (10.7)Ga-Adangbe8 (11.6)4 (7.3)23 (18.0)10 (13.3)Guan8 (11.6)7 (12.7)21 (16.4)11 (14.7)Mole-Dagbani17 (24.6)8 (14.5)23 (18.0)20 (26.7) Residence Rural11 (15.9)8 (14.5)14 (10.9) *12 (16.0)Peri-urban22 (31.9)9 (16.4)30 (23.4)20 (26.7)Urban36 (52.2)38 (69.1)84 (65.6)43 (57.3) Income No answer1 (1.4)1 (1.8)5 (3.9) *2 (2.7)< 10009 (13.0)11 (20.0)18 (14.1)12 (16.0)1000–300038 (55.1)30 (54.5)65 (50.8)37 (49.3)> 300021 (30.4)13 (23.6)40 (31.3)24 (32.0)Smoking1 (1.4)2 (3.6)3 (2.3)3 (4.0)Alcohol intake15 (21.7) *9 (16.4)17 (13.3)14 (18.7)*: P < 0.05; **: P < 0.01; ***P < 0.001. Socio-demographic characteristics stratified by measures of dyslipidemia. No formal education *: P < 0.05; **: P < 0.01; ***P < 0.001. Compared to those without formal education, participants with JHS (OR = 5.6, p = 0.01), SHS (OR = 2.8, p = 0.03), and tertiary (OR = 2.3, p = 0.05) education were more likely to have dyslipidaemia after adjusting for age. Those living in urban areas were about two times more likely to have dyslipidaemia (OR = 2.2, p = 0.01). Based on BMI, overweight (OR = 0.551, p = 0.03) and obese (OR = 0.467, p = 0.008) participants were less likely to have dyslipidaemia (Table 5). Table 5Univariate and multivariate logistic regression of factors associated with dyslipidemia.ParametersDyslipidemiaDyslipidemiaUnadjusted ORP-valueAge adjusted ORP-value Age group (yrs) ≤ 30131–401.919 (0.550–6.698)0.307--41–502.074 (0.626–6.875)0.233--51–602.550 (0.740–8.783)0.138--61–700.933 (0.246–3.536)0.919--> 703.200 (0.750-13.658)0.116-- Sex Male11Female1.246 (0.812–1.911)0.3141.244 (0.990–1.026)0.394 Educational level No formal education11Primary0.842 (0.128–5.561)0.8581.057 (0.153–7.285)0.955JHS4.421 (1.249–15.644) 0.021 5.512 (1.474–20.618) 0.011 SHS2.239 (1.009–4.969) 0.047 2.834 (1.142–7.030) 0.025 Tertiary1.791 (0.926–3.461)0.0832.328 (1.014–5.344) 0.046 Marital status Single1.369 (0.616–3.043)0.4412.283 (0.727–7.164)0.157Married1.422 (0.758–2.669)0.2731.710 (0.739–3.954)0.210Divorced1.506 (0.498–4.555)0.4681.807 (0.527–6.192)0.347Widowed1 Occupation Unemployed11Sedentary0.581 (0.197–1.715)0.3260.614 (0.193–1.949)0.408Non-sedentary1.227 (0.340–4.424)0.7541.303 (0.342–4.964)0.698 Residence Rural11Peri-urban1.871 (0.965–3.629)0.0641.944 (0.994–3.804)0.052Urban2.082 (1.165–3.722) 0.013 2.206 (1.208–4.028) 0.010 Income < 1000111000–30002.079 (1.182–3.655) 0.011 2.296 (1.248–4.221) 0.007 > 30002.629 (1.384–4.994) 0.003 2.950 (1.478–5.886) 0.002 Alcohol intake 1.398 (0.743–2.629)0.2981.411 (0.748–2.661)0.288 BMI Normal1Overweight0.552 (0.319–0.953) 0.033 0.551 (0.318–0.952) 0.033 Obese0.468 (0.268–0.817) 0.008 0.467 (0.267–0.817) 0.008 BP control Good1Poor0.701 (0.127–3.878)0.6840.705 (0.127–3.909)0.689 Univariate and multivariate logistic regression of factors associated with dyslipidemia. Participants aged 31–40 years were more likely to have high total cholesterol levels (OR = 17.050, p = 0.04). Compared to unemployed participants, those with non-sedentary jobs were more likely to have low HDL levels (OR = 6.6, p < 0.02). Participants with JHS education and above were more likely to have low HDL levels. Those aged 41–50 years (OR = 10.227, p = 0.04), above 70 years (OR = 15.023, p = 0.02), and non-sedentary workers (OR = 6.618, p = 0.02) had higher odds of having low HDL. While being overweight (OR = 0.401, p = 0.001) and obese (OR = 0.432, p = 0.004) were protective against dyslipidaemia (Table 6). Table 6Determinants of abnormal total cholesterol, triglyceride and HDL.VariablesHigh TC P High TG P Low HDL P Age group (yrs) ≤ 3011131–4017.050 (1.208- 240.635) 0.036 0.927 (0.159- 5.421)0.9338.148 (0.900-73.740)0.06241–505.944 (0.492- 71.792)0.1611.199 (0.228- 6.297)0.83010.227 (1.176–88.956) 0.035 51–604.388 (0.365- 52.771)0.2440.691 (0.121- 3.949)0.6788.403 (0.949–74.410)0.05661–702.049 (0.132- 31.771)0.6080.456 (0.063- 3.322)0.4385.225 (0.546–49.994)0.151> 702.595 (0.155- 43.544)0.5082.207 (0.335- 14.551)0.41115.023 (1.518- 148.704) 0.021 Sex Male111Female1.982 (0.829- 4.737)0.1240.636 (0.341- 1.185)0.1541.834 (1.159–2.902) 0.010 Education No formal education111Primary6.600 (0.101- 429.305)0.376--2.836 (0.235–34.208)0.412JHS4.478 (0.441- 45.453)0.2050.176 (0.017- 1.781)0.14117.005 (3.941–73.379) < 0.001 SHS1.587 (0.268- 9.388)0.6110.463 (0.120- 1.795)0.2667.152 (2.110-24.247) 0.002 Tertiary3.697 (0.666- 20.532)0.1350.863 (0.259- 2.875)0.8108.006 (2.469–25.958) 0.001 Marital status Single0.857 (0.079- 9.271)0.8990.919 (0.163- 5.188)0.9243.298 (0.908–11.982)0.070Married0.854 (0.156- 4.660)0.8551.122 (0.306- 4.114)0.8622.303 (0.844–6.286)0.103Divorced1.162 (0.090- 15.074)0.9090.247 (0.022- 2.736)0.2543.647 (0.951–13.978)0.059Widowed111 Occupation Unemployed111Sedentary7.136 (0.943- 53.995)0.0570.249 (0.063- 0.975) 0.046 4.075 (0.919–18.061)0.064Non-Sedentary8.689 (0.905- 83.464)0.0610.146 (0.027- 0.790) 0.025 6.618 (1.322–33.130) 0.021 Residence Rural111Peri-urban2.323 (0.552- 9.776)0.2500.636 (0.214- 1.895)0.4172.115 (0.971–4.607)0.059Urban0.731 (0.204- 2.619)0.6301.645 (0.661- 4.097)0.2852.890 (1.421–5.877) 0.003 Income < 10001111000–30002.527 (0.698- 9.152)0.1580.882 (0.373- 2.090)0.7762.172 (1.083–4.356)0.029> 30001.823 (0.452- 7.355)0.3990.680 (0.254- 1.820)0.4422.798 (1.304–6.002) 0.008 Alcohol intake1.975 (0.639- 6.107)0.2371.046 (0.452- 2.422)0.9170.978 (0.509–1.882)0.948 Smoking 0.125 (0.010- 1.593)0.1093.741 (0.560- 24.990)0.1731.099 (0.182–6.644)0.918 BMI status Normal111Overweight1.058 (0.377- 2.970)0.9150.593 (0.278- 1.264)0.1760.401 (0.230–0.701) 0.001 Obese1.112 (0.367- 3.366)0.8510.674 (0.312- 1.455)0.3150.432 (0.245–0.765) 0.004 BP control Good111Poor0.490 (0.024- 10.156)0.6451.086 (0.109- 10.787)0.9441.201 (0.205–7.042)0.839 Determinants of abnormal total cholesterol, triglyceride and HDL. Non- Sedentary The determinants of abnormal LDL and non-HDL among the participants are shown in Table 7. Those with sedentary work were less likely to have high LDL (OR = 0.125, p = 0.03), while those with a history of smoking were more likely to have high LDL (OR = 19.805, p = 0.02). Also, participants who were married were more likely to have high non-HDL-c (OR = 0.357, p = 0.05). Table 7Determinants of abnormal LDL and non-HDL-c.VariablesHigh LDL P High Non-HDL-c P Age group (yrs) ≤ 301131–400.066 (0.005–2.237)0.3700.508 (0.115–2.237)0.37041–500.156 (0.016–1.535)0.1110.777 (0.187–3.228)0.72851–600.548 (0.056–5.365)0.6050.672 (0.153–2.942)0.59861–700.367 (0.031–4.385)0.4291.153 (0.242–5.489)0.858> 700.530 (0.040–6.938)0.6280.521 (0.094–2.884)0.455 Sex Male11Female0.422 (0.178–1.003)0.0510.922 (0.558–1.525)0.752 Education No formaleducation11Primary0.307 (0.005–18.450)0.5721.916 (0.148–24.822)0.619JHS0.359 (0.040–3.230)0.3611.249 (0.290–5.375)0.766SHS0.706 (0.134–3.726)0.6821.067 (0.362–3.145)0.906Tertiary0.267 (0.052–1.365)0.1130.610 (0.227–1.640)0.327 Marital status Single0.683 (0.057–8.102)0.7620.495 (0.128–1.913)0.308Married2.587 (0.506–13.229)0.2540.357 (0.129–0.984) 0.047 Divorced0.766 (0.063–9.317)0.8340.989 (0.231–4.229)0.988Widowed11 Occupation Unemployed11Sedentary0.125 (0.020–0.772) 0.025 0.465 (0.099–2.178)0.331Non-sedentary0.229 (0.029–1.834)0.1650.690 (0.121–3.924)0.676 Residence Rural11Peri-urban0.527 (0.125–2.212)0.3811.295 (0.597–2.810)0.513Urban1.235 (0.352–4.342)0.7421.201 (0.596–2.423)0.609 Income < 1000111000–30000.633 (0.184–2.169)0.4661.188 (0.594–2.374)0.627> 30000.980 (0.259–3.698)0.9761.511 (0.685–3.335)0.306 Alcohol intake 0.853 (0.269–2.705)0.7871.301 (0.612–2.767)0.494 Smoking 19.805 (1.497-262.098) 0.023 0.348 (0.027–4.451)0.417 BMI status Normal11Overweight0.790 (0.287–2.175)0.6491.555 (0.820–2.949)0.176Obese0.448 (0.149–1.343)0.1521.507 (0.793–2.861)0.210 BP control Good11Poor0.934 (0.044–20.014)0.9651.035 (0.134–7.973)0.974 Determinants of abnormal LDL and non-HDL-c. No formal education Discussion We assessed the prevalence and determinants of dyslipidaemia in hypertensive patients at Effia Nkwanta Regional Hospital, Ghana. Among 347 participants, 203 (58.5%) had dyslipidaemia, with 107 females (52.7%) and 96 males (47.3%). This prevalence aligns with a study in Ethiopia (48.39%)36. However, our findings showed a lower prevalence when compared to studies among university students and academic staff in Bangladesh (76%-85%)37. The differences may be due to the distinct populations; our participants had varied educational and occupational backgrounds, unlike the studies in Bangladesh, which focused on individuals with tertiary education. This prevalence could reflect the effects of higher education, including psychological stress and imbalanced lifestyles37. In contrast, a study in Shang hang District, Zhejiang Province, reported a lower prevalence of 35.96% among community adults38. This difference could be attributed to dietary variations and higher obesity rates in Ghana compared to China39,40. The link between hypertension and dyslipidaemia may help explain the high prevalence observed in our study. Hypertension damages the endothelium of blood vessels, impairing their function. This disrupts lipid metabolism, altering lipoprotein processing in the bloodstream and promoting dyslipidaemia25. The present study additionally assessed atherogenic lipid ratios including TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratios as indicators of cardiovascular risk. Participants with dyslipidaemia exhibited significantly elevated lipid ratios compared with those without dyslipidaemia, suggesting a more atherogenic lipid profile and increased cardiovascular risk burden. These ratios are clinically relevant because they provide a more integrated assessment of the balance between atherogenic and protective lipoproteins than isolated lipid parameters alone. Elevated TC/HDL-C and LDL-C/HDL-C ratios have been associated with increased risk of coronary artery disease and adverse cardiovascular outcomes, while elevated TG/HDL-C ratio has been linked with insulin resistance and metabolic dysfunction41–43. Male participants demonstrated significantly higher lipid ratios than females, which may reflect sex-related differences in lipid metabolism, body fat distribution, hormonal influences, and cardiometabolic risk patterns. Also, participants who engaged in physical activity had lower TG/HDL-C ratios, supporting evidence that regular physical activity improves triglyceride metabolism and HDL cholesterol levels44. Majority of participants were categorized as having low 10-year cardiovascular risk, a proportion of participants with dyslipidaemia fell within the moderate-to-high-risk categories. This finding suggests that despite relatively low estimated short-term risk among many participants, dyslipidaemia may still contribute to cumulative long-term cardiovascular burden in hypertensive populations. The lack of a statistically significant difference in WHO risk categories between participants with and without dyslipidaemia may be attributable to the multifactorial nature of cardiovascular risk estimation, which incorporates age, blood pressure, smoking status, and body mass index in addition to lipid-related abnormalities45. Our analysis also uncovered associations related to age and occupation. Participants aged 31–40 years were more likely to have high total cholesterol levels. This finding contrasts with population-based data, which usually show higher cholesterol burden in older adults. A U.S. survey reported the highest prevalence among individuals aged 40–59 years46. However, similar trends of early-onset dyslipidaemia have been reported in African populations, including studies in Ghana and Nigeria, where younger adults increasingly exhibit adverse lipid profiles due to urbanization, dietary transitions, and reduced physical activity7,47. This suggests that dyslipidaemia in our cohort may be emerging earlier in life, possibly reflecting lifestyle and metabolic changes in the local population. Similarly, we found that participants in non-sedentary occupations had higher odds of low HDL compared to unemployed participants. This is counterintuitive, because physical activity is generally associated with higher HDL levels48. One possible explanation is that occupational physical activity is not equivalent to structured leisure-time exercise; work-related tasks are often repetitive, strenuous, and performed under time pressure, which may not confer the same cardiometabolic benefits as purposeful aerobic or moderate physical activity. Moreover, work environments with high demands and effort-reward imbalance are associated with physiological stress responses, including activation of neuroendocrine pathways and systemic inflammation, which have been linked to adverse lipid profiles, particularly lower HDL levels. A large population-based studies have shown that work stress defined by effort-reward imbalance is associated with lower HDL cholesterol and altered metabolic biomarkers, independent of lifestyle factors (Magnusson Hanson et al., 2017). Additionally, evidence from epidemiological research indicates that job stress is significantly associated with dyslipidaemia, including low HDL-cholesterol, supporting the notion that psychosocial stress at work can negatively influence lipid metabolism49. These non-sedentary workers may not have the health-protective routines of formal exercise, explaining why they unexpectedly had lower HDL. Moreover, we observed that those with sedentary work were less likely to have high LDL. Again, this is at odds with general expectations, since a sedentary lifestyle is usually linked to worse lipid profiles. Physical activity is well established to improve the lipid profile48. Our finding could be due to unmeasured confounders or socio-economic differences: individuals in sedentary jobs might have different diets or healthcare access that protect against high LDL. We observed that overweight and obesity appeared protective against dyslipidaemia (AOR = 0.46, p = 0.008), a finding that contradicts many studies50–52. This paradoxical observation may be partly explained by differences in fat distribution patterns within the study population. Emerging evidence suggests that cardiometabolic risk is more strongly related to visceral and abdominal fat than to overall body mass. Individuals with predominantly subcutaneous fat deposition, particularly in the lower body, may remain metabolically healthy despite elevated BMI. This phenotype, often referred to as metabolically healthy obesity, is characterized by lower hepatic and visceral fat accumulation, preserved insulin sensitivity, and more favorable lipid profiles53. In our study, although BMI was higher among overweight and obese participants, waist–hip ratio—a proxy for central adiposity—was lower among those with dyslipidaemia, suggesting relatively lower abdominal fat deposition in some individuals. This pattern may partly explain the apparent protective association observed. However, detailed imaging or body composition analyses were not performed, limiting definitive conclusions. Urban participants were twice as likely to have dyslipidaemia compared to those in rural areas (AOR = 2.206, p = 0.01). There was a significant relationship between urbanization and the prevalence of dyslipidaemia among hypertensive patients. Low HDL was more prevalent in urban participants (65.6%) than in rural ones (10.9%), suggesting urban lifestyles contribute to higher obesity rates through processed food consumption and decreased physical activity54. Our analysis demonstrated that higher income levels were associated with an increased risk of dyslipidaemia, often due to greater access to unhealthy food options and sedentary lifestyles55. We found a significant association between coronary risk and dyslipidaemia (p < 0.0001). A 2020 study indicated that elevated serum levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TG) were positively associated with total CVD events56. Our study also indicated that increased non-HDL cholesterol was significantly associated with dyslipidaemia (p < 0.0001). Most participants with dyslipidaemia were aged 41–50 years (39.4%) and 51–60 years (25.1%), consistent with a similar study47. A study conducted in Mekelle city, Northern Ethiopia discusses the increased prevalence of dyslipidaemia among adults, attributing this rise to several factors, including metabolic changes, lifestyle habits, and the presence of comorbidities57. Significant association were found between residence, income, smoking, BMI grades, and dyslipidaemia (p ≤ 0.001). Smoking was significantly associated with increased LDL levels in participants, reinforcing the impact on lipid profiles58,54. In our study all participants who smoked had dyslipidaemia, highlighting the well-established relationship between tobacco use and adverse lipid profiles; multiple studies have shown that smokers tend to have higher total cholesterol, LDL-C, and triglycerides as well as lower HDL-C levels compared with non-smokers, contributing to an atherogenic lipid profile and increased cardiovascular risk59–61. For context, we also collected clinical symptom data. Hypertension is often clinically silent, but when symptoms do occur, they are typically nonspecific. In our cohort the most common complaints were early-morning headaches and palpitations (irregular heart rhythm). These symptoms align with published reports. A comprehensive study of hypertensive patients found that the predominant symptoms were headaches, dizziness, insomnia, and palpitations, with headaches being the most frequent complaint62. Our study had a few limitations. It was a single-center study, with patents recruited from a single hospital, which limits the generalizability of the results to the entire Ghanaian population. Additionally, we did not include a control group of individuals without hypertension, which would have provided a comparison group for those with hypertension. Furthermore, physical activity levels were self-reported by participants, which may not be entirely accurate. Conclusion Dyslipidaemia is highly prevalent among hypertensive patients at Effia Nkwanta Regional Hospital, affecting 58.5% and representing a major cardiovascular risk. Younger age, urban residence, higher income, smoking, and elevated coronary risk were key determinants, highlighting early metabolic risk linked to lifestyle and urbanization. BMI, waist–hip ratio, and occupational activity showed complex associations, with possible metabolically healthy obesity contributing to paradoxical findings. These findings emphasize the importance of developing targeted public health strategies to tackle dyslipidaemia among hypertensive patients, with a strong focus on encouraging lifestyle changes and managing risk factors. . Acknowledgements The Authors thank the staff of the Diabetic clinic of Effia Nkwanta Regional Hospital (ENRH) at the Western Region of Ghana for their enormous support and assistance. Author contributions RKDE and FAB conceived the research idea; RKDE, FAB and GPK supervised the study; JA, KNAA, ED, ROA, DD carried out patient recruitment and data collection; AOM, PA, JC performed data analysis; MA, SZ, FJH performed laboratory work. AA, IAG and GPK performed literature search and drafted the final manuscript. RKDE, JA, GPK, FAB, AA and IAG reviewed the manuscript. All authors read and agreed to the final manuscript. Data availability Data is available upon reasonable request. Declarations Competing interests The authors declare no competing interests. Ethical considerations The Declaration of Helsinki and local regulatory requirements were followed in conducting this study. The respondents were provided with the full details of the study and made to provide informed consent before being enrolled. Participant’s information was strictly kept anonymous and confidential. This study was approved by the ethics committee of ENRH. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Data is available upon reasonable request.